PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW145662View Pathway |
drug action
Sulfadimethoxine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:20 Last Updated: October 07, 2023 at 16:20 |
PW176356View Pathway |
Sulfadimethoxine Predicted Metabolism PathwayHomo sapiens
Metabolites of sildenafil are predicted with biotransformer.
|
Creator: Omolola Created On: December 07, 2023 at 15:29 Last Updated: December 07, 2023 at 15:29 |
PW145366View Pathway |
drug action
Sulfadoxine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:40 Last Updated: October 07, 2023 at 15:40 |
PW176404View Pathway |
Sulfadoxine Predicted Metabolism PathwayHomo sapiens
Metabolites of Sulfadoxine are predicted with biotransformer.
|
Creator: Omolola Created On: December 07, 2023 at 16:53 Last Updated: December 07, 2023 at 16:53 |
PW128416View Pathway |
drug action
Sulfamerazine Action PathwayEscherichia coli (strain K12)
Sulfamerazine is an antibacterial agent from the sulfanilamide drug class. It is indicated in the treatment of many infections like bronchitis, prostatitis, and urinary tract infections. Sulfamerazine is a competitive inhibitor of the dihydropteroate synthetase (DHPS). This enzyme is essential in the synthesis of folic acids from para-aminobenzoic acid (PABA) molecules. Sulfamerazine is bacteriostatic, it stops the growth of the bacteria by decreasing the synthesis of bacterial nucleotides and DNA. This drug is administered as an oral tablet.
|
Creator: Daphnee Created On: August 28, 2023 at 12:44 Last Updated: August 28, 2023 at 12:44 |
PW145452View Pathway |
drug action
Sulfamerazine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:51 Last Updated: October 07, 2023 at 15:51 |
PW176405View Pathway |
Sulfamerazine Predicted Metabolism PathwayHomo sapiens
Metabolites of Sulfamerazine are predicted with biotransformer.
|
Creator: Omolola Created On: December 07, 2023 at 16:54 Last Updated: December 07, 2023 at 16:54 |
PW128452View Pathway |
drug action
Sulfameter Action PathwayEscherichia coli (strain K12)
Sulfameter, also known as sulfamethoxydiazine, is a long-acting antibacterial from the sulfonamide drug class. This drug is indicated in the treatment of leprosy, and urinary, and respiratory tract infections. It shows bacteriostatic effects against gram-positive and gram-negative bacteria. Sulfameter is a competitive inhibitor of the enzyme dihydropteroate synthase. This enzyme does the condensation of para-aminobenzoic acid (PABA) to produce folic acids. Without the synthesis of folate, the bacteria can not grow (bacteriostatic). Sulfameter is given orally as a tablet.
|
Creator: Daphnee Created On: August 29, 2023 at 12:04 Last Updated: August 29, 2023 at 12:04 |
PW145821View Pathway |
drug action
Sulfameter Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:45 Last Updated: October 07, 2023 at 16:45 |
PW176137View Pathway |
Sulfameter Predicted Metabolism Pathway newHomo sapiens
Metabolites of Sulfameter are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:14 Last Updated: November 29, 2023 at 14:14 |